INS and Alzheimer disease: Studies in cells (33), animals (66), and patients (10, 59) suggest that it may be useful in common neurodegenerative diseases, such as Parkinson’s and Alzheimer’s diseases, as well as in insulin-resistant states, such as trauma, heart failure, and diabetes (67).